JPRN-UMIN000010970招募中未知
Elucidation of renal function protection with human atrial natriuretic peptide (hANP) - Elucidation of renal function protection with hANP
Department of anesthesiology, Faculty of medicine,Kagawa university0 个研究点目标入组 30 人开始时间: 2013年6月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •preoperative renal disfunction , not heart failure
研究者
相似试验
已完成
不适用
Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period)Chronic renal failure patient with hypertension under going rennin-angiotensin treatment (ARB/ACE-inhibitor) (preservation period)JPRN-UMIN000002478Kure Kyousai Hospital200
尚未招募
不适用
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinomaJPRN-UMIN000013867Kansai Medical University30
已完成
不适用
The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.living donor renal transplantationJPRN-UMIN000014279Toho University School of Medicine, Department of Anesthesiology30
已完成
不适用
An observational study of renal protection by intravenous amino acid therapy in abdominal aortic aneurysm surgeryabdominal aortic aneurysmJPRN-UMIN000038527ational Cerebral and Cardiovascular Center2,000
进行中（未招募）
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851EUCTR2014-005033-31-FRAddmedica S.A.S